FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy

Pen technology aids trial adaptations

Free Newsletter

FierceBiotech IT updates senior biotech, pharma, and IT leaders on how IT advances are shaping clinical trials and clinical research. Get your weekly briefing on clinical trial design and management systems, adaptive trials, eClinical trials, and more. Sign up today!



Tools

Health Decisions has added digital pens to its adaptive clinical trial arsenal. The contract researcher is equipping investigators with pen/paper technology from Anoto, based in Sweden.

Investigators use the pens to log trial data; the pens record the data and convert it to digital format, says a trade publication. CRO and sponsor can then share the data once it's been downloaded and collated.

Health Decisions sees the technology as an aid to trial adaptation: It can keep both parties current with trial progress in a more timely fashion than that of more commonly used data-capture technologies. So trial managers will receive cues that drive trial adaptations earlier in the process.

- see the article

Related Articles:
Adaptive trials stretch toward agile
Adaptive trial network expands south


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotechIT Email Newsletter:

More stories about adaptive clinical trials   Health Decisions   Anoto